ADTXOTCPharmaceutical PreparationsFiscal year ends December 31

Aditxt, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00−0.00 (-16.67%)

Close on Oct 19, 2026

Market cap: $20
P/E (TTM): –
Dividend yield: –

Dividends

Aditxt has not reported a dividend

No dividend per share appears in Aditxt's annual filings since fiscal 2018.

Where these numbers come from

Parsed from the XBRL in Aditxt's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-27 reverse split on May 18, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADTX.

Company	Revenue	Growth
LNAI	$51.99K	–
ADTX	$14.34K	-74.1%
PRFX	–	–
GNLX	–	–
KPRX	–	–
AZTR	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Auditor: dbbmckennon
SEC CIK: 1726711

Advertisement
300 × 250